Buy GERN 11.83

[saad2004]

Buy GERN 11.83

 

[saad2004]

GERN resistance at 12.15,12.45

 

[saad2004]

(GERN) Geron Reports Presentation of Further Results of Telomerase Cancer Vaccine Clinical Trial at Duke University Medical Center- presentation reported that all but one of the patients in the clinical trial evaluated so far showed strong telomerase-specific cellular immune responses, that no patients exhibited any sign of treatment-related adverse effects